Investigation of CBS, MTR, RFC-1 and TC polymorphisms as maternal risk factors for Down syndrome

Disease Markers

Volumn 26, Issue 4, 2009, Pages 155-161

  Fintelman Rodrigues, N ^a   Correa J C ^a   Santos, J M ^a   Pimentel, M M G ^a   Santos Reboucas C B ^a  

^a STATE UNIVERSITY OF RIO DE JANEIRO   (Brazil)

Author keywords

Down syndrome; Folate; Polymorphisms; TC

Indexed keywords

5,10 METHYLENETETRAHYDROFOLATE REDUCTASE (FADH2); CYSTATHIONINE BETA SYNTHASE; FOLIC ACID; GENOMIC DNA; METHIONINE SYNTHASE; METHIONINE SYNTHASE REDUCTASE; REDUCED FOLATE CARRIER; REDUCED FOLATE CARRIER 1; TRANSCOBALAMIN; UNCLASSIFIED DRUG;

ADULT; ALLELE; AMINO ACID SUBSTITUTION; ARTICLE; BRAZIL; CONTROLLED STUDY; DISEASE PREDISPOSITION; DNA POLYMORPHISM; DOWN SYNDROME; FEMALE; FOLATE METABOLISM; GENE FREQUENCY; GENE INTERACTION; GENETIC ASSOCIATION; GENETIC RISK; GENETIC SUSCEPTIBILITY; GENETIC VARIABILITY; GENOTYPE; HUMAN; PRIORITY JOURNAL; RISK FACTOR; TRISOMY 21;

EID: 70349142200     PISSN: 02780240     EISSN: None     Source Type: Journal    
DOI: 10.3233/DMA-2009-0626     Document Type: Article

References (36)

1. S.E. Antonarakis and C.J. Epstein, The challenge of Down syndrome, Mol Med 12 (2006), 473-479.
2. J.M. Biselli, E.M. Goloni-Bertollo, B.L. Zampieri, R. Had-dad, M.N. Eberlin and E.C. Pavarino-Bertelli, Genetic polymorphisms involved in folate metabolism and elevated plasma concentrations of homocysteine: maternal risk factors for Down syndrome in Brazil, Genet Mol Res 7 (2008), 33-42.
3. J.M. Biselli, D. Brumati, V.F. Frigeri, B.L. Zampieri, E.M. Goloni-Bertollo and E.C. Pavarino-Bertelli, A80G polymorphism of reduced folate carrier 1 (RFC1) and C776G polymorphism of transcobalamin 2 (TC2) genes in Down's syndrome etiology, Sao Paulo Med J 126 (2008), 329-332.
4. P. Bosco, R.M. Gueant-Rodriguez, G. Anello, C. Barone, F. Namour, F. Caraci, A. Romano, C. Romano and J.L. Guéant, Methionine synthase (MTR) 2756 (A G) polymorphism, double heterozygosity methionine synthase 2756 AG/methionine synthase reductase (MTRR) 66AG, and elevated homocysteinemia are three risk factors for having a child with Down syndrome, Am J Med Genet 121 (2003), 219-224.
5. A.L. Boyles, A.V. Billups, K.L. Deak, D.G. Siegel, L. Mehltretter, S.H. Slifer, A.G. Bassuk, J.A. Kessler, M.C. Reed, H.F. Nijhout, T.M. George, D.S. Enterline, J.R. Gilbert and M.C. Speer, Neural tube defects and folate pathway genes: family-based association tests of gene-gene and gene-environment interactions, Environ Health Perspect 114 (2006), 1547-1552.
6. C. Butler, A.J. Knox, J. Bowersox, S. Forbes and D. Patterson, The production of transgenic mice expressing human cystathionine beta-synthase to study Down syndrome, Behav Genet 36 (2006), 429-438.
7. B. Chadefaux-Vekemans, M. Coude, F. Muller, J.F. Oury, A. Chabli, J. Jaïs and P. Kamoun, Methylenetetrahydrofolate re-ductase polymorphism in the etiology of Down syndrome, Pediatr Res 51 (2002), 766-767.
8. A. Chango, N. Fillon-Emery, C. Mircher, H. Blehaut, D. Lam- bért, B. Herbeth, S.J. James, M.O. Rethoré and J.P. Nicolas, No association between common polymorphisms in genes of folate and homocysteine metabolism and the risk of Down's syndrome among French mothers, Br J Nutr 94 (2005), 166-169.
9. F. Coppede, G. Marini, S. Bargagna et al., Folate gene poly- morphisms and the risk of Down syndrome pregnancies in young Italian women, Am J Med Genet A 140 (2006), 1083-1091.
10. L.R. da Silva, N. Vergani, Galdieri et al., Relationship between polymorphisms in genes involved in homocysteine metabolism and maternal risk for Down syndrome in Brazil, Am J Med Genet 135 (2005), 263-267.
11. S.J. Duthie, S. Narayanan, L. Sharp, J. Little, G. Basten and H. Powers, Folate, DNA stability and colo-rectal neoplasia, Proc Nutr Soc 63 (2004), 571-578.
12. T.K. Eskes, Abnormal folate metabolism in mothers with Down syndrome offspring: Review of the literature, Eur J Obstet Gynecol Reprod Biol 124 (2005), 130-133.
13. J.L. Gueant, N.W. Chabi, R.M. Gu eant-Rodriguez, O.M. Mut- chinick, R. Debard, C. Payet, X. Lu, C. Villaume, J.P. Bronow-icki, E.V. Quadros, A. Sanni, E. Amouzou, B. Xia, M. Chen, G. Anello, P. Bosco, C. Romano, H.R. Arrieta, B.E. Sanchez, A. Romano, B. Herbeth, W. Anwar and F. Namour, Environmental influence on the worldwide prevalence of a 776CG variant in the transcobalamin gene (TCN2), J Med Genet 44 (2007), 363-367.
14. R.M. Gueant-Rodriguez, C. Rendelib, B. Namour, L. Venuti, A. Romano, G. Anello, P. Bosco, R. Debard, P. Gerard, M. Viola, E. Salvaggio and J.L. Gueant, Transcobalamin and methionine synthase reductase mutated polymorphisms aggravate the risk of neural tube defects in humans, Neurosc Lett 344 (2003), 189-192.
15. D. Hernandez and E.M. Fisher, Down syndrome genetics: unravelling a multifactorial disorder, Hum Mol Genet 5 (1996), 1411-1416.
16. M. Klerk, K.J. Lievers, L.A. Kluijtmans, H.J. Blom, M. den Heijer, E.G. Schouten, F.J. Kok and P. Verhoef, The 2756A G variant in the gene encoding methionine synthase: its relation with plasma homocysteine levels and risk of coronary heart disease in a Dutch case-control study, Thromb Res 110 (2003), 87-91.
17. S.J. James, M. Pogribna, L.P. Pogribny, S. Melnyk, R.J. Hine, J.B. Gibson, P. Yi, D.L. Tafoya, D.H. Swenson, V.L. Wilson and D.W. Gaylor, Abnormal folate metabolism and mutation in the methylenetetrahydrofolate reductase gene may be maternal risk factors for Down syndrome, Am J Clin Nutr 70 (1999), 495-501.
18. H. McNulty and K. Pentieva, Folate bioavailability, Proc Nutr Soc 63 (2004), 529-536.
19. F. Namour, J.L. Olivier and I. Abdelmouttaleb, Transcobal-amin codon 259 polymorphism in HT-29 and Caco-2 cells and in Caucasians: relation to transcobalamin and homocysteine concentration in blood, Blood 97 (2001), 1092-1098.
20. T.T. Nguyen, D.L. Dyer, D.D. Dunning, S.A. Rubin, K.E. Grant and H.M. Said, Human intestinal folate transport: cloning, expression, and distribution of complementary RNA, Gastroenterology 112 (1997), 783-791.
21. J.R. Pimenta, L.W. Zuccherato, A.A. Debes, L. Maselli, R.P. Soares, R.S. Moura-Neto, J. Rocha, S.P. Bydlowski and S.D. Pena, Color and genomic ancestry in Brazilians: a study with forensic microsatellites, Hum Hered 62 (2006), 190-195.
22. C.B. Santos-Rebouças and M.M.G. Pimentel, Implication of abnormal epigenetic patterns for human diseases, Eur J Hum Genet 15 (2007), 10-17.
23. C.B. Santos-Rebouças, J.C. Corrêa, A. Bonomo, N. Fintelman-Rodrigues, K.C. Moura, C.S. Rodrigues, J.M. San-tos and M.M. Pimentel, The impact of folate pathway polymorphisms combined to nutritional deficiency as a maternal predisposition factor for Down syndrome, Dis Markers 25 (2008), 149-157.
24. I. Scala, B. Granese, M. Sellito, S. Salome, A. Sammartino, A. Pepe, P. Mastroiacovo, G. Sebastio and G. Andria, Analysis of seven maternal polymorphisms of genes involved in homocysteine/folate metabolism and risk of Down syndrome offspring, Genet Med 8 (2006), 409-416.
25. F. Sheth, S. Rao, M. Desai, J. Vin and J. Sheth, Cytogenetic analysis of Down syndrome in Gujarat, Indian Pediatr 44 (2007), 774-776.
26. C.M. Summers, A.L. Hammons, L.E. Mitchell, J.V. Wood-side, J.W. Yarnell, I.S. Young, A. Evans and A.S. White-head, Influence of the cystathionine beta-synthase 844ins68 and methylenetetrahydrofolate reductase 677CT polymorphisms on folate and homocysteine concentrations, Eur J Hum Genet 16 (2008), 1010-1013.
27. N. Takamura, T. Kondoh, S. Ohgi, K. Arisawa, M. Mine, S. Yamashita and K. Aoyagi, Abnormal folic acid-homocysteine metabolism as maternal risk factors for Down syndrome in Japan, Eur J Nutr 43 (2004), 285-287.
28. M.Y. Tsai, U. Garg, N.S. Keyb, N.Q. Hanson, A. Suh and K. Schwichtenberg, Molecular and biochemical approaches in the identification of heterozygotes for homocystinuria, Atherosclerosis 132 (1996), 69-77.
29. C.L. Ulrey, L. Liu, L.G. Andrews and T.O. Tollefsbol, The impact of metabolism on DNA methylation, Hum Mol Genet 14 (2005), 139-147.
30. I.J.M. van der Linden, L.A. Afman, S.G. Heil and H.J. Blom, Genetic variation in genes of folate metabolism and neural-tube defect risk, Proc Nutr Soc 65 (2006), 204-215.
31. N.M.J. van der Put, E.F. Van Der Molen, L.A.J. Kluijtmans, S.G. Heil, J.M. Trijbels, T.K. Eskes, D. Van Oppenraaij-Emmerzaal, R. Banerjee and H.J. Blom, Sequence analysis of the coding region of human methionine synthase: relevance to hyperhomocysteinaemia in neural-tube defects and vascular disease, Q J Med 90 (1997), 511-517.
32. K.M. von Castel-Dunwoody, G.P.A. Kauwell, K.P. Shelnutt, J.D. Vaughn, E.R. Griffin, D.R. Maneval, D.W. Theriaque and L.B. Bailey, Transcobalamin 776CG polymorphism negatively affects vitamin B-12 metabolism, Am J Clin Nutr 81 (2005), 1436-1441.
33. W.C. Winkelmayer, C. Eberly, G. Sunder-Plassmann and M. Fodinger, Effects of the glutamate carboxypeptidase II (GCP2 1561CT) and reduced folate carrier (RFC-1 80At-Rodriguez R.G) allelic variants on folate and total homocysteine levels in kidney transplant patients, Kidney Int 63 (2003), 2280-2285.
34. Z. Yates and M. Lucock, G80A reduced folate carrier SNP modulates cellular uptake of folate and affords protection against thrombosis via a non homocysteine related mechanism, Life Sci 77 (2005), 2735-2742.
35. S.S. Young, B. Eskenazi, F.M. Marchetti, G. Block and A.J. Wyrobek, The association of folate, zinc and antioxidant intake with sperm aneuploidy in healthy non-smoking men, Hum Reprod 23 (2008), 1014-1022.
36. A. Zijno, C. Andreoli, P. Leopardi, F. Marcon, S. Rossi, S. Caiola, A. Verdina, R. Galati, A. Cafolla and R. Crebelli, Fo-late status, metabolic genotype, and biomarkers of genotoxic-ity healthy subjects, Carcinogenesis 24 (2003), 1097-1103.